NHS Connecting for Health ceased to exist on 31st March 2013. This website is therefore not being updated. For up to date information about systems and services visit the Health and Social Care Information Centre website at www.hscic.gov.uk/systems

You are here: Home Services & Applications Data Standards NHS Classifications Service Standards and Audit OPCS-4 Classification Chemotherapy regimens and high cost drugs

Chemotherapy Regimens and High Cost Drugs

The NHS Classifications Service collaborates with the Department of Health and NHS Information Centre for health and social care on the use of OPCS-4 within national data collections.

DH Chemotherapy Regimens list

The Department of Health (DH) - Payment by Results team produce the list of Chemotherapy Regimens to enable the collection, reporting and costing of chemotherapy regimens (drug administration) procurement and delivery data to support the development of a national tariff for chemotherapy services in NHS, England.

The NHS Information Centre for health and social care manages the updating of the list on behalf of the DH in collaboration with the National Cancer Action Team.  Any new and changed content is quality assured by the DH Oncology Regimens Steering Group made up of pharmacists, paediatric oncologists and cost accountants to ensure it is accurate and fit for purpose.

DH High Cost Drugs list

The DH Payment by Results (PbR) team produce the list of High Cost Drugs excluded from tariff. These drugs are typically used in a relatively small number of specialist centres rather than across all Trusts.  To ensure fair reimbursement these drugs are excluded from the Payment by Results tariff and additional funding is agreed locally over and above the national mandatory tariff.

The DH Payment by Results team reviews and updates the High Cost Drugs on an annual basis.  Consequently clinical coding guidance is updated by the NHS Classifications Service to align it with the updated list.

The DH PbR team manages the updating of the list in collaboration with the NHS Information Centre and its High Cost Drugs Steering Group.  New and changed content is agreed by members of the steering group which includes operational NHS pharmacists and consultants.

The DH approves the final list of high cost drugs and maps for release to the NHS.

Clinical coding guidance

The NHS Classifications Service develops and maintains the OPCS-4 classification and the associated national clinical coding standards.  This includes the provision of clinical coding guidance for use with the DH Chemotherapy Regimens and High Cost Drugs Lists

Chemotherapy Regimens and High Cost Drugs lists and guidance 2012-13

The DH Chemotherapy Regimens, High Cost Drugs lists and clinical coding guidance documents are released via the Technology Reference Data Update Distribution Service (TRUD). This distribution service has been revised and an updated website has been launched with improved functionality.

The files and supporting documentation are available from the distribution service are:

  • DH Chemotherapy Regimens List 2012-13 V2.0
  • Chemotherapy Regimens Clinical Coding Guidance OPCS-4.6 (April 2012) V2.0
  • DH High Cost Drugs List 2012-13 V2.0
  • High Cost Drugs Clinical Coding Guidance OPCS-4.6 (April 2012) V2.0

By issuing the key documents via this controlled distribution mechanism registered users receive an automatic notification that updates are available for download. 

For more information and to register visit the NHS Classifications Service section of the distribution service website.

Chemotherapy Regimens and High Cost Drugs requests for change

The Department of Health provide a Chemotherapy Regimens requests portal and High Cost Drugs requests portal for changes to be suggested.